Nihar R. Desai

1 month ago | ajmc.com | Kyle Munz |Nihar R. Desai

The Pragmatic Trial of Messaging to Providers (PROMPT) Trials are a series of randomized studies that focus on implementing electronic medical-based alerts to enhance patients outcomes and overall care. At present, these trials are grouped into 4 divisions: lipids, heart failure (HF) inpatient, HF outpatient, and magnetic resonance angiography (MRA).

Jan 22, 2025 | medscape.com | Nihar R. Desai |Ankeet S. Bhatt |Tariq Ahmad

Authors and Disclosures Nihar R. Desai, MD, MPH Associate Professor of Medicine, Cardiovascular Medicine, Yale University School of Medicine; Vice Chief, Cardiovascular Medicine, Yale New Haven Health, New Haven, ConnecticutDisclosure: Nihar R.

Nov 4, 2024 | onlinelibrary.wiley.com | Nihar R. Desai |Auro Viswabandya |Temerty Faculty |Jeffrey Lipton

Conflicts of Interest The authors declare no conflicts of interest. References 1, , , , and , “Post–Hematopoietic Stem Cell Transplantation Immune-Mediated Anemia: A Literature Review and Novel Therapeutics,” Blood Advances 6, no. 8 (2022): 2707–2721. 2, , , and , “Daratumumab for Delayed Red-Cell Engraftment After Allogeneic Transplantation,” New England Journal of Medicine 379, no. 19 (2018): 1846–1850.

Oct 17, 2024 | medscape.com | Nihar R. Desai |Seth Martin

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nihar R. Desai, MD, MPH: I'm Dr Nihar Desai from the Yale School of Medicine. Welcome to season one of the Medscape InDiscussion cardiorenal metabolic (CRM) syndrome podcast series. Today, we're discussing low-density lipoprotein (LDL) cholesterol, dyslipidemia, and lipoprotein(a) [Lp(a)].

Sep 29, 2024 | oncodaily.com | Nihar R. Desai

Nihar Desai, Co-Founder, HaemBytes, shared a post on X:“Join me in Nashville, TN this October. The Binaytara Foundation 2024 Summit on Hematological Cancers is here!Register.”Source: Nihar Desai/X